Substance Abuse and Mental Health Services Administration (2011). Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings (NSDUH) Series H-41, Issue.
Altman, D. G., & Bland, J. M. (2011). How to obtain the P value from a confidence interval. Bmj, 343, d2304. https://doi.org/10.1136/bmj.d2304
Amon, J. J., Garfein, R. S., Ahdieh-Grant, L., Armstrong, G. L., Ouellet, L. J., Latka, M. H., Vlahov, D., Strathdee, S. A., Hudson, S. M., Kerndt, P., Jarlais, D. D., & Williams, I. T. (2008). Prevalence of Hepatitis C Virus Infection among Injection Drug Users in the United States, 1994–2004. Clinical Infectious Diseases, 46(12), 1852-1858. https://doi.org/10.1086/588297
Batchelder, A. W., & Lounsbury, D. W. (2016). Simulating syndemic risk: Using system dynamics modeling to understand psycho-social challenges facing women living with and at-risk for HIV. In Handbook of Applied System Science (pp. 84-106). Taylor and Francis Inc. https://doi.org/10.4324/9781315748771
Beijer, U., Wolf, A., & Fazel, S. (2012). Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis. Lancet Infect Dis, 12(11), 859-870. https://doi.org/10.1016/s1473-3099(12)70177-9
Bluthenthal, R. N., Wenger, L., Chu, D., Bourgois, P., & Kral, A. H. (2017). Drug use generations and patterns of injection drug use: Birth cohort differences among people who inject drugs in Los Angeles and San Francisco, California. Drug Alcohol Depend, 175, 210-218. https://doi.org/10.1016/j.drugalcdep.2017.04.001
Bruneau, J., Roy, E., Arruda, N., Zang, G., & Jutras-Aswad, D. (2012). The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users. Addiction, 107(7), 1318-1327. https://doi.org/10.1111/j.1360-0443.2012.03803.x
Centers for Disease Control and Prevention (2019). Surveillance for Viral Hepatitis – United States, 2017. Centers for Disease Control and Prevention. https://www.cdc.gov/hepatitis/statistics/2017surveillance/index.htm
Centers for Disease Control and Prevention (2020). Viral Hepatitis Surveillance Report 2018 — Hepatitis C. https://www.cdc.gov/hepatitis/statistics/2018surveillance/HepC.htm
Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014). The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry, 71(7), 821-826. https://doi.org/10.1001/jamapsychiatry.2014.366
Craine, N., Hickman, M., Parry, J. V., Smith, J., Walker, A. M., Russell, D., Nix, B., May, M., McDonald, T., & Lyons, M. (2009). Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size. Epidemiol Infect, 137(9), 1255-1265. https://doi.org/10.1017/s095026880900212x
Diaz, T., Des Jarlais, D. C., Vlahov, D., Perlis, T. E., Edwards, V., Friedman, S. R., Rockwell, R., Hoover, D., Williams, I. T., & Monterroso, E. R. (2001). Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health, 91(1), 23-30. https://doi.org/10.2105/ajph.91.1.23
Dolan, K. A., Shearer, J., White, B., Zhou, J., Kaldor, J., & Wodak, A. D. (2005). Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. Addiction, 100(6), 820-828. https://doi.org/10.1111/j.1360-0443.2005.01050.x
Eckhardt, B., Winkelstein, E. R., Shu, M. A., Carden, M. R., McKnight, C., Des Jarlais, D. C., Glesby, M. J., Marks, K., & Edlin, B. R. (2017). Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention. PLoS One, 12(5), e0177341. https://doi.org/10.1371/journal.pone.0177341
Guarino, H., Marsch, L. A., Deren, S., Straussner, S. L., & Teper, A. (2015). Opioid Use Trajectories, Injection Drug Use, and Hepatitis C Virus Risk Among Young Adult Immigrants from the Former Soviet Union Living in New York City. J Addict Dis, 34(2-3), 162-177. https://doi.org/10.1080/10550887.2015.1059711
Guarino, H., Mateu-Gelabert, P., Teubl, J., & Goodbody, E. (2018). Young adults' opioid use trajectories: From nonmedical prescription opioid use to heroin, drug injection, drug treatment and overdose. Addict Behav, 86, 118-123. https://doi.org/10.1016/j.addbeh.2018.04.017
Hagan, H., Pouget, E. R., Williams, I. T., Garfein, R. L., Strathdee, S. A., Hudson, S. M., Latka, M. H., & Ouellet, L. J. (2010). Attribution of Hepatitis C Virus Seroconversion Risk in Young Injection Drug Users in 5 US Cities. The Journal of Infectious Diseases, 201(3), 378-385. www.jstor.org/stable/27794429
Havens, J. R., Lofwall, M. R., Frost, S. D., Oser, C. B., Leukefeld, C. G., & Crosby, R. A. (2013). Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. Am J Public Health, 103(1), e44-52. https://doi.org/10.2105/ajph.2012.300874
Homer, J., Hirsch, G., & Milstein, B. (2007). Chronic illness in a complex health economy: The perils and promises of downstream and upstream reforms. System Dynamics Review, 23, 313-343. https://doi.org/10.1002/sdr.379
Homer, J., & Wakeland, W. (2020). A dynamic model of the opioid drug epidemic with implications for policy. The American journal of drug and alcohol abuse, 1-11. https://doi.org/10.1080/00952990.2020.1755677
Hosmer, J. D. W., Lemeshow, S., & Sturdivant, R. X. (2013). Applied logistic regression (Vol. 398). John Wiley & Sons.
Hovmand, P. S. (2014). Introduction to Community-Based System Dynamics. In Community Based System Dynamics (pp. 1-16). Springer New York. https://doi.org/10.1007/978-1-4614-8763-0_1
Jordan, A. E., Des Jarlais, D. C., Arasteh, K., McKnight, C., Nash, D., & Perlman, D. C. (2015). Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013. Drug Alcohol Depend, 152, 194-200. https://doi.org/10.1016/j.drugalcdep.2015.03.039
Kapadia, S. N., Katzman, C., Fong, C., Eckhardt, B. J., Guarino, H., & Mateu-Gelabert, P. (2021). Hepatitis C testing and treatment uptake among young people who use opioids in New York City: A cross-sectional study. Journal of Viral Hepatitis, 28(2), 326-333. https://doi.org/https://doi.org/10.1111/jvh.13437
Katzman, C., Mateu-Gelabert, P., Kapadia, S. N., & Eckhardt, B. J. (2019). Contact tracing for hepatitis C: The case for novel screening strategies as we strive for viral elimination. Int J Drug Policy, 72, 33-39. https://doi.org/10.1016/j.drugpo.2019.04.003
Kermack, W. O., McKendrick, A. G., & Walker, G. T. (1927). A contribution to the mathematical theory of epidemics. Proceedings of the Royal Society of London. Series A, Containing Papers of a Mathematical and Physical Character, 115(772), 700-721. https://doi.org/doi:10.1098/rspa.1927.0118
Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015). The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction. Annual Review of Public Health, 36(1), 559-574. https://doi.org/10.1146/annurev-publhealth-031914-122957
Lankenau, S., Kecojevic, A., & Silva, K. (2015). Associations between prescription opioid injection and Hepatitis C virus among young injection drug users. Drugs: Education, Prevention and Policy, 22(1), 35-42. https://doi.org/10.3109/09687637.2014.970515
Liang, T. J., & Ward, J. W. (2018). Hepatitis C in Injection-Drug Users - A Hidden Danger of the Opioid Epidemic. N Engl J Med, 378(13), 1169-1171. https://doi.org/10.1056/NEJMp1716871
Macalino, G. E., Hou, J. C., Kumar, M. S., Taylor, L. E., Sumantera, I. G., & Rich, J. D. (2004). Hepatitis C infection and incarcerated populations. International Journal of Drug Policy, 15(2), 103-114. https://doi.org/https://doi.org/10.1016/j.drugpo.2003.10.006
Martin, N. K., Hickman, M., Hutchinson, S. J., Goldberg, D. J., & Vickerman, P. (2013). Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. Clin Infect Dis, 57 Suppl 2(Suppl 2), S39-45. https://doi.org/10.1093/cid/cit296
Mateu-Gelabert, P., & Guarino, H. (2018). The opioid epidemic and injection drug use: MIPIE and health harms related to the injection of prescription opioids. International Journal of Drug Policy, 57, 130-132. https://doi.org/https://doi.org/10.1016/j.drugpo.2018.03.019
Mateu-Gelabert, P., Guarino, H., Jessell, L., Syckes, C., & Friedman, S. R. (2015). Risks associated with nonmedical prescription opioid use: Transition to heroin use and drug injection, overdose and hepatitis C. Drug and Alcohol Dependence, 156, e141-e142. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2015.07.387
Mateu-Gelabert, P., Guarino, H., Jessell, L., & Teper, A. (2015). Injection and sexual HIV/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City. Journal of Substance Abuse Treatment, 48(1), 13-20. https://doi.org/https://doi.org/10.1016/j.jsat.2014.07.002
Mateu-Gelabert, P., Guarino, H., Quinn, K., Meylakhs, P., Campos, S., Meylakhs, A., Berbesi, D., Toro-Tobón, D., Goodbody, E., Ompad, D. C., & Friedman, S. R. (2018). Young Drug Users: a Vulnerable Population and an Underutilized Resource in HIV/HCV Prevention. Current HIV/AIDS Reports, 15(4), 324-335. https://doi.org/10.1007/s11904-018-0406-z
Mateu-Gelabert, P., Guarino, H., Zibbell, J. E., Teubl, J., Fong, C., Goodbody, E., Edlin, B., Salvati, C., & Friedman, S. R. (2020). Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose. Harm Reduction Journal, 17(1), 22. https://doi.org/10.1186/s12954-020-00367-2
New York City Department of Health and Mental Hygiene (2019). Hepatitis A, B and C in New York City: 2018 Annual Report. https://www1.nyc.gov/assets/doh/downloads/pdf/cd/hepatitis-abc-annual-report-2018.pdf
Nyamathi, A. M., Dixon, E. L., Robbins, W., Smith, C., Wiley, D., Leake, B., Longshore, D., & Gelberg, L. (2002). Risk factors for hepatitis C virus infection among homeless adults. J Gen Intern Med, 17(2), 134-143. https://doi.org/10.1046/j.1525-1497.2002.10415.x
Olaya, C. (2015). Cows, agency, and the significance of operational thinking. System Dynamics Review, 31(4), 183-219. https://doi.org/10.1002/sdr.1547
Perlman, D. C., & Jordan, A. E. (2018). The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions. Curr HIV/AIDS Rep, 15(2), 96-112. https://doi.org/10.1007/s11904-018-0390-3
Quinn, K., Fong, C., Guarino, H., & Mateu-Gelabert, P. (2019). Development, validation, and potential applications of the hepatitis C virus injection-risk knowledge scale (HCV-IRKS) among young opioid users in New York City. Drug and Alcohol Dependence, 194, 453-459. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2018.11.010
Rajan, S., Ruggles, K. V., Guarino, H., & Mateu-Gelabert, P. (2018). Heroin Use and Drug Injection among Youth Also Misusing Prescription Drugs. Am J Health Behav, 42(1), 144-155. https://doi.org/10.5993/ajhb.42.1.14
Richardson, G. (2011). Reflections on the Foundations of System Dynamics. System Dynamics Review, 27, 219-243. https://doi.org/10.1002/sdr.462
Sharareh, N., S Sabounchi, N., Sayama, H., & MacDonald, R. (2016). The Ebola Crisis and the Corresponding Public Behavior: A System Dynamics Approach. PLoS currents, 8, ecurrents.outbreaks.23badd9821870a9821002fa9821886bef9826893c9821801d. https://doi.org/10.1371/currents.outbreaks.23badd9821870a002fa86bef6893c01d
Sterman, J. D. (2006). Learning from evidence in a complex world. Am J Public Health, 96(3), 505-514. https://doi.org/10.2105/ajph.2005.066043
Stone, J., Fraser, H., Lim, A. G., Walker, J. G., Ward, Z., MacGregor, L., Trickey, A., Abbott, S., Strathdee, S. A., Abramovitz, D., Maher, L., Iversen, J., Bruneau, J., Zang, G., Garfein, R. S., Yen, Y.-F., Azim, T., Mehta, S. H., Milloy, M.-J., Hellard, M. E., Sacks-Davis, R., Dietze, P. M., Aitken, C., Aladashvili, M., Tsertsvadze, T., Mravčík, V., Alary, M., Roy, E., Smyrnov, P., Sazonova, Y., Young, A. M., Havens, J. R., Hope, V. D., Desai, M., Heinsbroek, E., Hutchinson, S. J., Palmateer, N. E., McAuley, A., Platt, L., Martin, N. K., Altice, F. L., Hickman, M., & Vickerman, P. (2018). Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. The Lancet Infectious Diseases, 18(12), 1397-1409. https://doi.org/https://doi.org/10.1016/S1473-3099(18)30469-9
Valdiserri, R., Khalsa, J., Dan, C., Holmberg, S., Zibbell, J., Holtzman, D., Lubran, R., & Compton, W. (2014). Confronting the emerging epidemic of HCV infection among young injection drug users. Am J Public Health, 104(5), 816-821. https://doi.org/10.2105/ajph.2013.301812
Van Handel, M. M., Rose, C. E., Hallisey, E. J., Kolling, J. L., Zibbell, J. E., Lewis, B., Bohm, M. K., Jones, C. M., Flanagan, B. E., Siddiqi, A. E., Iqbal, K., Dent, A. L., Mermin, J. H., McCray, E., Ward, J. W., & Brooks, J. T. (2016). County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States. J Acquir Immune Defic Syndr, 73(3), 323-331. https://doi.org/10.1097/qai.0000000000001098
Wakeland, W., Nielsen, A., & Geissert, P. (2015). Dynamic model of nonmedical opioid use trajectories and potential policy interventions. The American journal of drug and alcohol abuse, 41(6), 508-518. https://doi.org/10.3109/00952990.2015.1043435
Wakeland, W., Nielsen, A., & Schmidt, T. D. (2016). Gaining Policy Insight with a System Dynamics Model of Pain Medicine Prescribing, Diversion and Abuse. Systems Research and Behavioral Science, 33(3), 400-412. https://doi.org/10.1002/sres.2345
Wakeland, W., Schmidt, T., Gilson, A. M., Haddox, J. D., & Webster, L. R. (2011). System dynamics modeling as a potentially useful tool in analyzing mitigation strategies to reduce overdose deaths associated with pharmaceutical opioid treatment of chronic pain. Pain Med, 12 Suppl 2, S49-58. https://doi.org/10.1111/j.1526-4637.2011.01127.x
Zibbell, J. E., Asher, A. K., Patel, R. C., Kupronis, B., Iqbal, K., Ward, J. W., & Holtzman, D. (2018). Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014. Am J Public Health, 108(2), 175-181. https://doi.org/10.2105/ajph.2017.304132
Zibbell, J. E., Hart-Malloy, R., Barry, J., Fan, L., & Flanigan, C. (2014). Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics. Am J Public Health, 104(11), 2226-2232. https://doi.org/10.2105/ajph.2014.302142
Zibbell, J. E., Iqbal, K., Patel, R. C., Suryaprasad, A., Sanders, K. J., Moore-Moravian, L., Serrecchia, J., Blankenship, S., Ward, J. W., & Holtzman, D. (2015). Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012. MMWR Morb Mortal Wkly Rep, 64(17), 453-458.